Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Kiniksa Pharmaceuticals International Plc (NQ: KNSA ) 21.48 -1.00 (-4.45%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 445,222 Open 22.26 Bid (Size) 20.26 (1) Ask (Size) 20.52 (1) Prev. Close 22.48 Today's Range 21.44 - 22.26 52wk Range 14.12 - 28.15 Shares Outstanding 71,726,685 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Exploring Kiniksa Pharmaceuticals's Earnings Expectations October 28, 2024 Via Benzinga NHL Hall-of-Famer, Henrik Lundqvist, Teams Up with Kiniksa Pharmaceuticals to Launch Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis October 01, 2024 – Life DisRPted is an educational campaign aimed at promoting early diagnosis and treatment of recurrent pericarditis, a painful and debilitating chronic autoinflammatory disease – From Kiniksa Pharmaceuticals, Ltd. Via GlobeNewswire Performance YTD +15.92% +15.92% 1 Month -12.25% -12.25% 3 Month -10.91% -10.91% 6 Month +7.45% +7.45% 1 Year +33.17% +33.17% More News Read More KNSA Stock Earnings: Kiniksa Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024 July 23, 2024 Via InvestorPlace Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday July 23, 2024 Via Benzinga Earnings Outlook For Kiniksa Pharmaceuticals February 27, 2024 Via Benzinga Earnings Outlook For Kiniksa Pharmaceuticals October 30, 2023 Via Benzinga Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 23, 2024 Via Benzinga Sector Spotlight: Orphan Drug Developers With Significant Upside June 03, 2024 Via AB Newswire Topics ETFs Exposures Product Safety Sector Spotlight: Orphan Drug Developers With Significant Upside June 03, 2024 Via TheNewswire.com Topics ETFs Exposures Product Safety KNSA Stock Earnings: Kiniksa Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024 April 23, 2024 Via InvestorPlace Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session January 02, 2024 Via Benzinga The 3 Most Undervalued Biotech Stocks to Buy in December December 15, 2023 Via InvestorPlace Earnings Scheduled For April 23, 2024 April 23, 2024 Via Benzinga 7 Underappreciated Biotech Stocks to Pick Up on the Cheap November 09, 2023 Via InvestorPlace Topics Economy Exposures Economy Amicus Therapeutics Stock Reaches 80+ Relative Strength Benchmark September 28, 2023 Via Investor's Business Daily 5 Value Stocks In The Healthcare Sector September 11, 2023 Via Benzinga 5 Value Stocks To Watch In The Healthcare Sector August 21, 2023 Via Benzinga Vertex Pharmaceuticals Stock Shows Rising Relative Strength, Hits 80+ August 16, 2023 Via Investor's Business Daily ACELYRIN Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold August 15, 2023 Via Investor's Business Daily Axsome Therapeutics Stock Earns Relative Strength Rating Upgrade August 15, 2023 Via Investor's Business Daily Exelixis Stock Sees Rising Relative Strength Rating August 14, 2023 Via Investor's Business Daily Dynavax Technologies Stock Sees Renewed Technical Strength August 07, 2023 Via Investor's Business Daily Crude Oil Up 1%; Verizon Earnings Beat Views July 25, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session July 25, 2023 Via Benzinga Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 25, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
